Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Italiano

Showing results (81-90 of 418) with videos related to

Pageof 42
Sort By:
Future Oncology (London, England)|July 19, 2021
Precision oncology: a clinical and patient perspectiveUlrik N Lassen, Lydia E Makaroff, Albrecht Stenzinger, et al.
European Journal of Radiology|December 12, 2018
MRI assessment of surrounding tissues in soft-tissue sarcoma during neoadjuvant chemotherapy can help predicting response and prognosisAmandine Crombé, François Le Loarer, Eberhard Stoeckle, et al.
Cancer Research Communications|October 20, 2023
Antitumor Effects of PRMT5 Inhibition in SarcomasStéphanie Verbeke, Aurélien Bourdon, Jean-Philippe Guegan, et al.
European Radiology|July 25, 2018
High-grade soft-tissue sarcoma: optimizing injection improves MRI evaluation of tumor responseAmandine Crombé, François Le Loarer, François Cornelis, et al.
Experimental Hematology & Oncology|December 6, 2022
Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancerSophie Cousin, Maud Toulmonde, Michèle Kind, et al.
European Journal of Radiology|July 17, 2019
Abnormal vascularization of soft-tissue sarcomas on conventional MRI: Diagnostic and prognostic valuesPauline Ledoux, Michèle Kind, François Le Loarer, et al.
Critical Reviews in Oncology/Hematology|February 28, 2018
Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: A critical reviewMarion Savina, Sophie Gourgou, Antoine Italiano, et al.
Hematological Oncology|July 21, 2016
What are the challenges in 2016 regarding resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and cancer?Matthieu Lewis, Mhairi Copland, Simona Soverini, et al.
The American Journal of Managed Care|February 24, 2022
Diagnosis and management of TRK fusion cancerShivaani Kummar, Antoine Italiano, Marcia S Brose, et al.
Onkologie|November 7, 2013
Major efficacy of trabectedin in 2 metastatic osteosarcoma patients with wild-type Asp1104 ERCC5 tumor statusLauris Gastaud, Esma Saâda-Bouzid, Valérie Le Morvan, et al.
Pageof 42

Showing results (81-90 of 418) with videos related to

Sort By:
Pageof 42
Future Oncology (London, England)|July 19, 2021
Precision oncology: a clinical and patient perspectiveUlrik N Lassen, Lydia E Makaroff, Albrecht Stenzinger, et al.
European Journal of Radiology|December 12, 2018
MRI assessment of surrounding tissues in soft-tissue sarcoma during neoadjuvant chemotherapy can help predicting response and prognosisAmandine Crombé, François Le Loarer, Eberhard Stoeckle, et al.
Cancer Research Communications|October 20, 2023
Antitumor Effects of PRMT5 Inhibition in SarcomasStéphanie Verbeke, Aurélien Bourdon, Jean-Philippe Guegan, et al.
European Radiology|July 25, 2018
High-grade soft-tissue sarcoma: optimizing injection improves MRI evaluation of tumor responseAmandine Crombé, François Le Loarer, François Cornelis, et al.
Experimental Hematology & Oncology|December 6, 2022
Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancerSophie Cousin, Maud Toulmonde, Michèle Kind, et al.
European Journal of Radiology|July 17, 2019
Abnormal vascularization of soft-tissue sarcomas on conventional MRI: Diagnostic and prognostic valuesPauline Ledoux, Michèle Kind, François Le Loarer, et al.
Critical Reviews in Oncology/Hematology|February 28, 2018
Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: A critical reviewMarion Savina, Sophie Gourgou, Antoine Italiano, et al.
Hematological Oncology|July 21, 2016
What are the challenges in 2016 regarding resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and cancer?Matthieu Lewis, Mhairi Copland, Simona Soverini, et al.
The American Journal of Managed Care|February 24, 2022
Diagnosis and management of TRK fusion cancerShivaani Kummar, Antoine Italiano, Marcia S Brose, et al.
Onkologie|November 7, 2013
Major efficacy of trabectedin in 2 metastatic osteosarcoma patients with wild-type Asp1104 ERCC5 tumor statusLauris Gastaud, Esma Saâda-Bouzid, Valérie Le Morvan, et al.
Pageof 42